Rathbones Group’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,700
Closed -$76K 327
2017
Q3
$76K Sell
1,700
-40
-2% -$1.82K ﹤0.01% 301
2017
Q2
$85K Hold
1,740
﹤0.01% 299
2017
Q1
$126K Hold
1,740
0.01% 301
2016
Q4
$100K Hold
1,740
0.01% 300
2016
Q3
$223K Sell
1,740
-425
-20% -$54.4K 0.01% 277
2016
Q2
$270K Hold
2,165
0.01% 244
2016
Q1
$181K Hold
2,165
0.01% 273
2015
Q4
$197K Buy
2,165
+300
+16% +$32.2K 0.01% 267
2015
Q3
$229K Buy
1,865
+225
+14% +$30.5K 0.02% 261
2015
Q2
$252K Hold
1,640
0.02% 259
2015
Q1
$280K Hold
1,640
0.02% 255
2014
Q4
$251K Hold
1,640
0.02% 265
2014
Q3
$174K Hold
1,640
0.01% 281
2014
Q2
$249K Hold
1,640
0.02% 254
2014
Q1
$211K Buy
1,640
+40
+3% +$6.22K 0.02% 256
2013
Q4
$279K Hold
1,600
0.03% 177
2013
Q3
$258K Hold
1,600
0.03% 221
2013
Q2
$212K Buy
+1,600
New +$226K 0.03% 216

Other funds holding ELGX

Rathbones Group's ELGX Position: Q4 2017 in Review

Rathbones Group sold out of Endologix Inc (ELGX) in Q4 2017, closing a stake of 1,700 shares — an estimated $76K sold.

Rathbones Group first reported a position in ELGX in Q2 2013 and held it in 18 quarters. The position peaked at $280K in Q1 2015. 103 funds tracked by Wall St. Rank hold ELGX as of Q4 2017.

  • Rathbones Group reported no remaining Endologix Inc position as of Q4 2017 after selling out during the quarter.
  • Rathbones Group sold 1,700 Endologix Inc shares in Q4 2017, an estimated $76K.
  • Rathbones Group first reported a position in Endologix Inc in Q2 2013 and held it in 18 quarters.
  • Rathbones Group's Endologix Inc position peaked at $280K in Q1 2015.
  • 103 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2017.

Based on Rathbones Group's 13F filing for Q4 2017, filed 24 Jan 2018.